Fund cites GMED’s $10.93 billion market cap and $90 share price exceeding its $85 intrinsic value estimate.
Madison Small Cap Fund sold its entire stake in Globus Medical (GMED) during Q1 2026, ending a multi-year holding. The fund stated GMED’s market capitalization reached $10.93 billion, surpassing its $85 intrinsic value estimate, while the stock traded at $90 per share.
Globus Medical reported Q1 2026 revenue of $759.9 million, a 27% year-over-year increase, driven by Nuvasive acquisition integration and robotics platform adoption. The stock rose 36.71% over the past 52 weeks, closing at $80.52 on June 11, 2026.
Hedge fund ownership of GMED increased to 52 portfolios in Q1 2026, up from 42 in the prior quarter, though the stock was not among the most popular hedge fund holdings heading into 2026.